255 related articles for article (PubMed ID: 19028605)
21. Decreased serum levels of transforming growth factor-beta1 in patients with autism.
Okada K; Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Sugiyama T; Kawai M; Minabe Y; Takei N; Mori N
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):187-90. PubMed ID: 17030376
[TBL] [Abstract][Full Text] [Related]
22. Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration.
Saurina A; Campistol JM; Lario S; Oppenheimer F; Diekmann F
Transplant Proc; 2007 Sep; 39(7):2138-41. PubMed ID: 17889117
[TBL] [Abstract][Full Text] [Related]
23. Increased plasma levels of cystatin C and transforming growth factor-beta1 in patients with coronary artery ectasia: can there be a potential interaction between cystatin C and transforming growth factor-beta1.
Yetkin E; Acikgoz N; Sivri N; Tekin GO; Yagmur J; Aksoy Y; Turhan H
Coron Artery Dis; 2007 May; 18(3):211-4. PubMed ID: 17429295
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
25. [Serum levels analysis of TGF-Beta and VEGF in patients with cancer anorexia-cachexia syndrome in lung cancer].
Kosacka M; Weryńska B; Gołecki M; Porebska I; Passowicz-Muszyńska E; Jankowska R
Wiad Lek; 2007; 60(7-8):335-40. PubMed ID: 18175552
[TBL] [Abstract][Full Text] [Related]
26. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment.
Zhou Q; Zhu XQ; Zhang J; Xu ZL; Lu P; Wu F
Ultrasound Med Biol; 2008 Jan; 34(1):81-7. PubMed ID: 17854983
[TBL] [Abstract][Full Text] [Related]
27. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
28. Distribution of IgG4- and/or IgG-positive plasma cells in Hashimoto's thyroiditis: an immunohistochemical study.
Kojima M; Hirokawa M; Kuma H; Nishihara E; Masawa N; Nakamura N; Miyauchi A
Pathobiology; 2010; 77(5):267-72. PubMed ID: 21116118
[TBL] [Abstract][Full Text] [Related]
29. Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto's thyroiditis*.
Nielsen CH; Brix TH; Gardas A; Banga JP; Hegedüs L
Clin Endocrinol (Oxf); 2008 Oct; 69(4):664-8. PubMed ID: 18363888
[TBL] [Abstract][Full Text] [Related]
30. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of papillary carcinoma and Hashimoto's thyroiditis.
Matesa-Anić D; Matesa N; Dabelić N; Kusić Z
Acta Clin Croat; 2009 Mar; 48(1):9-12. PubMed ID: 19623865
[TBL] [Abstract][Full Text] [Related]
32. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
[TBL] [Abstract][Full Text] [Related]
33. Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.
Meki AR; Al-Shobaili H
J Clin Lab Anal; 2014 Nov; 28(6):496-501. PubMed ID: 24659464
[TBL] [Abstract][Full Text] [Related]
34. [Hashimoto's thyroiditis and autoimmunity parameters: descriptive study].
Fiducia M; Lauretta R; Lunghi R; Kyanvash S; Pallotti S
Minerva Med; 2007 Apr; 98(2):95-9. PubMed ID: 17519851
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis.
Li Y; Bai Y; Liu Z; Ozaki T; Taniguchi E; Mori I; Nagayama K; Nakamura H; Kakudo K
Pathol Int; 2009 Sep; 59(9):636-41. PubMed ID: 19712131
[TBL] [Abstract][Full Text] [Related]
36. Distribution of serum immunoglobulin G4 levels in Hashimoto's thyroiditis and clinical features of Hashimoto's thyroiditis with elevated serum immunoglobulin G4 levels.
Takeshima K; Ariyasu H; Inaba H; Inagaki Y; Yamaoka H; Furukawa Y; Doi A; Furuta H; Nishi M; Akamizu T
Endocr J; 2015; 62(8):711-7. PubMed ID: 25994040
[TBL] [Abstract][Full Text] [Related]
37. Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia.
Giordano P; Lenato GM; Pierucci P; Suppressa P; Altomare M; Del Vecchio G; Di Bitonto G; De Mattia D; Guanti G; Sabbà C
J Pediatr Hematol Oncol; 2009 Aug; 31(8):577-82. PubMed ID: 19636272
[TBL] [Abstract][Full Text] [Related]
38. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto's thyroiditis compared to other thyroid illnesses.
Müssig K; Leyhe T; Holzmüller S; Klein R; Weinert C; Saur R; Klingberg S; Häring HU; Gallwitz B
Psychoneuroendocrinology; 2009 Sep; 34(8):1252-6. PubMed ID: 19375868
[TBL] [Abstract][Full Text] [Related]
39. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium.
Vega JL; Puebla C; Vásquez R; Farías M; Alarcón J; Pastor-Anglada M; Krause B; Casanello P; Sobrevia L
Cardiovasc Res; 2009 Jun; 82(3):458-67. PubMed ID: 19193655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
